HIV in the News

Published on: August 27, 2015
Gilead Sciences has applied for approval of Truvada (tenofovir/emtricitabine) as pre-exposure prophylaxis (PrEP) in Canada.
Published on: August 26, 2015
A study of PrEP among Brazilian transgender women and gay and bi men has found that those at highest risk of HIV were the most likely to participate.
Published on: August 25, 2015
Lentiviruses, the class of viruses to which HIV belongs, are estimated to have infected primates as far back as 16 million years ago.
Published on: August 24, 2015
Among those coinfected with HIV, a cure for hepatitis C is linked with improvements in liver stiffness, even if they have cirrhosis.
Published on: August 24, 2015
HIV specialists may be much less likely than hepatologists to screen for hepatocellular carcinoma (HCC, the most common form of liver cancer) among those with hepatitis B.
Published on: August 21, 2015
Mistakenly believing that antiretrovirals and illicit drugs are a toxic mix, many people with HIV intentionally skip their ARVs when they plan to use such substances.
Published on: August 20, 2015
The rates of people living with HIV in Ontario, Canada, who are in medical care and who have an undetectable viral load are nearing United Nations targets for what it would take to send the HIV epidemic into a significant retreat.
Published on: August 19, 2015
Relying solely on a liver biopsy to diagnose cirrhosis among people with hepatitis C likely misses three in four cases of the advanced stage of liver disease.
Published on: August 19, 2015
Youths who contracted HIV at birth may lack immunity to measles, mumps and rubella despite vaccination for the three diseases.
Published on: August 18, 2015
AIDS Healthcare Foundation, which has long waged a vociferous and largely isolated battle against Truvada as PrEP, has finally begun to capitulate, offering measured support for the HIV prevention method.